AptarGroup (ATR) was featured on a list of Dividend Champion vs Aristocrats: 12 Under the Radar Stocks to Buy. The company has a global presence, with half of revenue in Europe and 33% in North America. Since 2016, they have completed nearly 24 acquisitions, investments, and partnerships, expanding their reach.

In the first quarter of 2025, AptarGroup (ATR) reported mixed earnings. Revenue was $887 million, a 3% decline from last year. Pharma’s drug delivery systems saw a 2% increase in reported sales and a 4% rise in core sales. The company experienced high demand for dosing, dispensing, and protection technologies.

AptarGroup (ATR) had a strong cash position in the quarter, with operating cash flow at $82.7 million and free cash flow at $25.8 million. They returned $110 million to shareholders through dividends, with 31 years of consistent increases. Currently paying a quarterly dividend of $0.45 per share with a 1.11% yield as of July 23.

While AptarGroup (ATR) shows investment potential, certain AI stocks may offer greater upside potential with less downside risk. For an undervalued AI stock poised to benefit from Trump-era tariffs and onshoring trends, check out a free report on the best short-term AI stock.

Read more at Yahoo Finance: The Unsung Hero of Reliable Dividend Growth